Marijuana Moment by By Kyle Jaeger 11/26/2019
Legalization advocates aren’t the only ones who recognize that marijuana’s current restrictive federal classification inhibits research. Recently, a group involving several of the nation’s leading prohibition supporters raised this issue with Congress.
Friends of the National Institute On Drug Abuse (FNIDA) submitted recommended language on the issue to a Senate committee, voicing concern that the the status of cannabis and other drugs as a Schedule I controlled substances is preventing scientists from conducting valuable research.
Here’s what FNIDA urged the committee to adopt:
“Barriers to Research—The Committee is concerned that restrictions associated with Schedule 1 of the Controlled Substance Act [CSA] effectively limit the amount and type of research that can be conducted on certain Schedule 1 drugs, especially marijuana or its component chemicals and certain synthetic drugs. At a time when we need as much information as possible about these drugs, we should be lowering regulatory and other barriers to conducting this research. The Committee directs NIDA to provide a short report on the barriers to research that result from the classification of drugs and compounds as Schedule 1 substances.â€
More:
https://www.marijuanamoment.net/marijuana-legalization-opponents-admit-federal-law-is-blocking-research/